reviewThe Lancet NeurologyOct 1, 2002Closed access

Why did NMDA receptor antagonists fail clinical trials for stroke and traumatic brain injury?

CIChrysanthy IkonomidouLTLechosław Turski

Humboldt-Universität zu Berlin · Charité - Universitätsmedizin Berlin · +1 more institution

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

725
total citations
FWCI
4.75
Percentile
100%
References
45
Citations per year

Authors

2

Topics & keywords

Topics
Keywords
  • NMDA receptor
  • Excitotoxicity
  • Traumatic brain injury
  • Glutamate receptor
  • Stroke (engine)
  • Neuroscience
  • Medicine
  • Blockade
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.